Therapy Areas: Cardiovascular
Medicure introduces ReDSTM PRO system
18 September 2019 -

It was reported yesterday that Medicure Inc (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, has launched its new ReDSTM PRO System of lung fluid management technology for heart failure.

The product was launched at the recent Heart Failure Society of America conference in Philadelphia, Pennysylavania. It is optimised for the point-of-care market aimed at use in hospitals and sub-acute facilities. It uses non-invasive low energy radio frequency technology that produces reliable fluid volume readings after 45 seconds of measurement.

ReDSTM PRO can be used throughout hospital facilities, from the emergency department to discharge and subacute rehabilitation.

Login
Username:

Password: